Screening, case finding and evidence-based guidelines

---

• 1.
• Mornson AS. Screening. In: Rothman KJ, Greenland S, editors. Modern epidemiology. Philadelphia: Lippincott-Raven, 1998; 499.
• 2.
• Mulley AG, Barry MJ. Controversy in managing patients with prostate cancer. Banish dogma, get more data [editorial]. BMJ 1998; 316: 1919-1920.
• 3.
• Woolf SH. Screening for prostate cancer with prostate-specific antigen -- an examination of the evidence. N Engl J Med 1995; 333: 1401-1405.
• 4.
• Feeney T. To screen or not to screen. In: Fundamentals of prostate cancer detection and treatment [web site]. <http://rattler.cameron.edu/ww/index.html>. Revised 27 January 1999. Accessed 1 September 1999.
• 5.
• Coley CM, Barry MJ, Fleming C, et al. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. Ann Intern Med 1997; 126: 468-479.
• 6.
• Australian Cancer Society. Prostate cancer screening: guidelines for health professionals. Cancer Forum 1995; 19: 47-50.
• 7.
• Australian Health Technology Advisory Committee. Prostate cancer screening. Canberra: AGPS, 1996.
• 8.
• Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 4th ed. Sydney: RACGP, 1996; 26.
• 9.
• National Health and Medical Research Council. Clinical practice guidelines. The management of uncomplicated lower urinary tract symptoms in men. Canberra: Commonwealth of Australia, 1997.
• 10.
• Girgis S, Ward JE, Thomson CJH. General practitioners' perceptions of medicolegal risk. Using case scenarios to assess the potential impact of prostate cancer screening guidelines. Med J Aust 1999; 171: 362-366.
• 11.
• Girgis S, Ward JE, Thomson CJH. Potential impact using case scenarios of guidelines discouraging prostate cancer screening on general practitioners' perceptions of medicolegal risk [second revised version with peer review discussion]. <http://www.mja.com.au/public/issues/iprs2/girgis/girgisframe.html>. Accessed 1 September 1999.
• 12.
• Kramer BS, Brown ML, Prorok PC, et al. Prostate cancer screening: what we know and what we need to know. Ann Intern Med 1993; 119: 914-923.
• 13.
• Auvinen A, Tammela T, Stenman U-H, et al. Screening for prostate cancer using serum prostate-specific antigen: a randomised population-based pilot study in Finland. Br J Cancer 1996; 74: 568-572.